Jean Bennett of the Perelman School of Medicine comments on the benefits of applying gene therapy to eye diseases.
Perelman School of Medicine
The percentage of HIV patients taking antiretroviral drugs who experienced the full benefit of the drugs jumped from 45 percent of 72 percent during the past decade, a figure that is lower than previous estimates.
Susan Ellenberg of the Perelman School of Medicine comments on a study about newer cancer drugs.
Helen Glassberg of the Perelman School of Medicine comments on a study about the impact of stressful jobs on the heart health of women.
David Gaieski of the Perelman School of Medicine is quoted about warning signs of sepsis.
While clinical trial results are being released regarding drugs intended to decrease amyloid production - thought to contribute to decline in Alzheimer's disease - clinical trials of drugs targeting other disease proteins, such as tau, are in their initial phases.